查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496007

全球腦監測系統市場 – 2024 年至 2029 年預測

Global Brain Monitoring Systems Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 138 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

腦監測系統市場預計將以 8.03% 的複合年成長率成長，從 2022 年的 23.45 億美元增至 2029 年的 40.27 億美元。

在神經系統檢查中，大腦監測系統用於識別腦細胞（神經元）功能異常，這些異常會導致帕金森氏症、癲癇、阿茲海默症、睡眠障礙等神經系統疾病的發生。這些技術可以監測和檢測神經元活動，而無需進行侵入性腦部手術。監測腦外傷患者變得越來越重要，以避免進一步的腦損傷，特別是腦缺血。

在患者監測中評估顱內壓升高 (ICP) 的需求日益成長，推動了對腦監測設備的需求。根據美國國家心理健康美國(NIMH) 2020 年的一項研究，四分之一的美國患有可診斷的精神疾病，約 6% 的人患有嚴重殘疾。此外，同樣的估計也顯示，美國每年因嚴重精神疾病造成的總費用超過 3,170 億美元。因此，市場在預測期內也可能成長。

腦監測市場競爭相對激烈，參與企業市場。就市場佔有率而言，一些重要的公司現在在特定領域的分析市場中佔據主導地位。然而，隨著技術的進步和產品的突破，中小型公司正在透過提供新的​​、更易於使用的技術來增加其在市場上的影響力。

市場促進因素：

  • 人口老化、腦部疾病盛行率的增加以及電子產品的便利性可能會推動市場成長。

創傷性腦損傷 (TBI) 是美國死亡和殘疾的主要原因。 TBI 約佔所有傷害死亡率的 30%。在美國，每天有 153 人死於包括 TBI 在內的傷害（資料來源：疾病美國與預防中心）。此外，由於生活環境的變化和壓力水平的增加，醫療保健支出的增加和神經病變發病率的增加正在推動市場的成長。

此外，不斷進步的技術進步為腦感測器的發展提供了機會，從而推動了預測期內全球腦監測設備的成長。此外，第一版腦電圖監測儀充滿了電纜和電極，今天的大多數設備仍然基於這種傳統架構。然而，自從引入無線連接以來，使用腦電圖監視器和其他相關設備的尺寸和難度已顯著降低。

  • 設備技術創新的不斷發展預計將增加對大腦監測系統的需求。

各種神經退化性疾病和神經系統疾病的盛行率不斷上升，增加了行動腦電圖設備、即時監測和警報的創新頻率，這促進了對腦監測產品的需求。根據美國國家神經疾病和中風研究所的數據，僅在美國就有大約 3000 萬人患有大約 7,000 種已確診的罕見和超罕見疾病中的至少一種。超過45%的罕見疾病伴隨神經系統症狀。預計這些因素將激增對大腦監測產品的需求並推動市場發展。

此外，預計越來越多的大腦健康設備的監管核准將推動大腦監測系統市場的成長。一些醫院和醫療機構正在將大腦植入植入神經病變風險的患者體內，以人為地控制大腦功能。此外，創新和先進的大腦健康設備的監管核准預計將在不久的將來推動市場成長。例如，2019 年 4 月，GE Healthcare 的新型 Revolution Apex電腦斷層掃描器影像重建引擎獲得了美國食品藥物管理局510(k) 許可。

市場主要發展：

  • 2024 年 1 月—國家幹細胞基金會 (NSCF) 將利用國際太空站的微重力環境來研究帕金森氏症和 PPMS 患者的腦類器官。這次任務是 NSCF 的第五次飛行，將收集有關大腦組織變化和發炎的資料。這些資料將為基金會的下一個任務提供訊息，其中包括從受影響患者身上採集的誘導性多功能幹細胞的類器官。
  • 2022 年 11 月 - FDA核准Neurosteer 的單通道 EEG 大腦監測平台用於臨床。該平台能夠持續監測阿茲海默症、帕金森氏症和失智症疾病的無症狀性認知能力下降。該平台還將有助於藥物治療的臨床試驗，並促進對神經退化患者進行具有成本效益的大批量篩檢。較短的設定時間和機器學習功能可以客觀、輕鬆地評估認知狀態。
  • 2022 年 10 月 -Medtronic推出美敦力神經血管聯合實驗室 (TM)，這是一個針對中風治療新概念的創新流程和平台。該平台收集並討論醫生、發明家、企業家和新興企業改善中風護理的想法。我們的團隊分析想法並選擇最佳的投資於研究和原型開發。該平台還有助於將治療方法推進到臨床和商業階段。
  • 2022 年 2 月 - Masimo 獲得 FDA 批准用於 1-17 歲兒童患者的 SedLine® 腦功能監測和 SedLine 兒科腦電圖感測器。將 SedLine 的潛在益處擴大到美國所有 1 歲以上患者，是提高最具挑戰性和最年輕大腦患者護理品質的重要一步。 SedLine 使用先進的訊號處理技術來監測兩側的大腦活動，為臨床醫生提供大腦的整體情況，以幫助個人化 Sedangia 並偵測警訊。

公司產品

  • 雙頻指數 (TM) (BIS(TM)) 是一種監測技術，可增強臨床醫生以患者為導向的採用、維護和出現方法。 BIS(TM) 技術可非侵入性地測量和解釋與麻醉劑效果直接相關的腦電波活動。
  • SedLine® 腦功能監測是一種大腦監測系統，可幫助臨床醫生監測麻醉下大腦的狀態。取得雙邊資料和處理腦電圖訊號有助於臨床醫生管理麻醉。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球腦監測系統市場：依產品類型

  • 介紹
  • 腦電圖（EEG）
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 腦磁圖（MEG）
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 磁振造影(MRI)
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 腦血氧計
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章全球腦監測系統市場：依應用分類

  • 介紹
  • 創傷性腦損傷 (TBI)
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 癲癇
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 阿茲海默症
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第7章全球腦監測系統市場：依最終用戶分類

  • 介紹
  • 醫院/診所
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 神經中樞
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 學術研究所
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第8章全球腦監測系統市場：按地區分類

  • 介紹
  • 北美洲
    • 依產品類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 依產品類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 依產品類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 依產品類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 依產品類型
    • 按用途
    • 按最終用戶
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Compumedics Limited
  • GENERAL ELECTRIC COMPANY
  • Medtronic
  • Natus Medical Incorporated
  • NIHON KOHDEN CORPORATION
  • Tristan Technologies, Inc.
  • Masimo Corporation
  • Canon Medical Systems Corporation
  • CortiCare, Inc.
  • NeuroWave Systems Inc.
簡介目錄
Product Code: KSI061612145

The global brain monitoring systems market is projected to grow at a CAGR of 8.03% to reach US$4.027 billion by 2029, from US$2.345 billion in 2022.

In neurological testing, brain monitoring systems are used to identify any irregularity in the functionality of brain cells (neurons) that contributes to the development of neurological illnesses such as Parkinson's disease, epilepsy, Alzheimer's, and sleep problems. These technologies enable the monitoring and detection of neuronal activity without the need for invasive neurosurgery. Monitoring patients with traumatic brain injuries is becoming increasingly important to avoid further brain damage, especially cerebral ischemia.

The rising need for evaluating elevated intracranial pressure (ICP) in monitoring patients will drive demand for brain monitoring devices. According to the US National Institute of Mental Health (NIMH) 2020, one in every four American individuals has a diagnosable mental condition in any given year, with almost 6% having a severe disability. Additionally, according to the same estimate, the overall annual cost of serious mental illness in the United States surpasses USD 317 billion. Therefore, this would also lead the market to grow during the projected period.

The brain monitoring market is relatively competitive, with both large and small industry participants. In terms of market share, a small number of significant firms now dominate the market analyzed in certain areas. However, with technological improvements and product breakthroughs, mid-size to smaller businesses have increased their market presence by bringing new, more usable technologies.

Market Drivers:

  • Aging demographics, increased prevalence of brain illnesses, and gadget simplicity would propel the market growth.

In the United States, traumatic brain injury (TBI) is a leading cause of mortality and disability. TBIs account for around 30% of all injury mortality. Every day, 153 people in the United States die from injuries that include TBI (source: Centers for Disease Control and Prevention). In addition, rising healthcare expenditure and high incidences of neurological disorders due to changing living conditions and increasing stress levels are driving the market growth.

Furthermore, the growing technological advancements will provide an opportunity for the development of brain sensors, which will boost the growth of global brain monitoring devices in the forecast period. Moreover, the first versions of EEG monitors were filled with cables and electrodes, and even today, the great majority of devices are based on this traditional architecture. However, with the introduction of wireless connectivity, the size and awkwardness of EEG monitors and other associated equipment have been greatly decreased.

  • Rising Innovation in the devices is anticipated to increase the demand for brain monitoring systems.

The rising prevalence of various neurodegenerative and neurological disorders has led to an increased frequency of innovation in mobile EEG devices, real-time monitoring, and alarms, which is thus contributing to the demand for brain monitoring products. According to the National Institute of Neurological Disorders and Stroke, about 30 million people in the US alone suffer from at least one of the nearly 7,000 identified uncommon or ultra-rare disorders. More than 45% of uncommon diseases are associated with neurological symptoms. Factors like this are thus expected to surge the demand for brain monitoring products thus driving the market.

Furthermore, a rising number of regulatory approvals for brain health devices is projected to drive the global brain monitoring systems market growth. Several hospitals and healthcare organizations implement the insertion of brain implants in patients who are at risk of developing neurological disorders to provide artificial control on brain functioning. Additionally, regulatory approvals for innovative and advanced brain health devices are predicted to propel the market growth in the near future. For instance, in April 2019, GE Healthcare received the US Food and Drug Administration 510(k) clearance for its Deep Learning Image Reconstruction engine on the new Revolution Apex computed tomography device.

Market Key Developments:

  • January 2024- The National Stem Cell Foundation (NSCF) is using the International Space Station's microgravity environment to study brain organoids from patients with Parkinson's and PPMS. The mission, marking NSCF's fifth flight, is to collect data on tissue changes and inflammation in the brain. The data will inform the foundation's next mission, which will include organoids from induced pluripotent stem cells from affected patients. A follow-on investigation will be launched on SpaceX's 30th Commercial Resupply Services mission, including organoids from patients with Alzheimer's disease.
  • November 2022- The FDA approved the Neurosteer single-channel EEG brain monitoring platform for clinical use. This platform allows for continuous monitoring of presymptomatic cognitive decline in diseases like Alzheimer's, Parkinson's, and dementia. The platform can also aid in clinical trials for pharmaceutical therapeutics, facilitating cost-effective mass screening of neurodegenerative patients. The short set-up time and machine-learning features make it objective and easy to assess cognitive states. The portable and affordable EEG system is now widely available to all populations.
  • October 2022- Medtronic launched the Medtronic Neurovascular Co-Lab(TM), an innovation process and platform for new ideas in stroke care. The platform collects and examines ideas from doctors, inventors, entrepreneurs, and startups to improve stroke care. A team analyzes the ideas and expedites the best ones for investment in research or prototype development. The platform can also help shepherd therapies through clinical and commercial stages. It highlighted two big needs for innovation in stroke care: innovations to extend the window of care and discover ways to foster brain tissue regrowth.
  • February 2022- Masimo received FDA clearance for SedLine(R) brain function monitoring for pediatric patients aged 1-17 years and the SedLine Pediatric EEG Sensor. This expansion of SedLine's potential benefits to all patients one year old and above in the United States is a significant step towards improving the quality of care for patients with challenging and youngest brains. SedLine uses advanced signal processing technology to monitor brain activity bilaterally, providing clinicians with a more complete picture of the brain, helping to personalize sedoanalgesia and detect warning signs.

Company Products:

  • Bispectral Index(TM) (BIS(TM)) is a monitoring technique that enhances the clinician's patient-targeted approach to induction, maintenance, and emergence. BIS(TM) technology non-invasively measures and interprets the wave activity of the brain directly related to the effects of anesthetic agents.
  • SedLine(R) Brain Function Monitoring is a brain monitoring system that helps clinicians monitor the state of the brain under anesthesia. It acquires bilateral data and processes EEG signals that help clinicians with anesthetic management.

Segmentation:

By Product Type

  • Electroencephalography (EEG)
  • Magnetoencephalography (MEG)
  • Magnetic Resonance Imaging (MRI)
  • Cerebral Oximeters
  • Others

By Application

  • Traumatic Brain Injury (TBI)
  • Epilepsy
  • Alzheimer's Disease
  • Others

By End-user

  • Hospitals & Clinics
  • Neurological Centers
  • Academic and Research Institutes

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits for the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL BRAIN MONITORING SYSTEMS MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Electroencephalography (EEG)
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Magnetoencephalography (MEG)
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Magnetic Resonance Imaging (MRI)
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Cerebral Oximeters
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Others
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL BRAIN MONITORING SYSTEMS MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Traumatic Brain Injury (TBI)
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Epilepsy
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Alzheimer's Disease
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. GLOBAL BRAIN MONITORING SYSTEMS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals & Clinics
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Neurological Centers
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Academic and Research Institutes
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. GLOBAL BRAIN MONITORING SYSTEMS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. By End User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. By End User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. France
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. United Kingdom
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Opportunities and Trends
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By End User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. By End User
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. Japan
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. South Korea
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. India
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Compumedics Limited
  • 10.2. GENERAL ELECTRIC COMPANY
  • 10.3. Medtronic
  • 10.4. Natus Medical Incorporated
  • 10.5. NIHON KOHDEN CORPORATION
  • 10.6. Tristan Technologies, Inc.
  • 10.7. Masimo Corporation
  • 10.8. Canon Medical Systems Corporation
  • 10.9. CortiCare, Inc.
  • 10.10. NeuroWave Systems Inc.